Susquehanna Fundamental Investments’s Chembio diagnostics, Inc. CEMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-29,000
Closed -$10K 1604
2022
Q3
$10K Buy
+29,000
New +$19.8K ﹤0.01% 1418
2022
Q1
$169K Sell
206,419
-2,261
-1% -$2.11K ﹤0.01% 1395
2021
Q4
$238K Buy
208,680
+29,000
+16% +$59K 0.01% 1185
2021
Q3
$449K Buy
+179,680
New +$498K 0.01% 1257
2021
Q2
Sell
-20,700
Closed -$73K 1856
2021
Q1
$73K Sell
20,700
-2,955
-12% -$16.5K ﹤0.01% 1484
2020
Q4
$112K Sell
23,655
-42,587
-64% -$220K ﹤0.01% 1416
2020
Q3
$322K Buy
66,242
+38,042
+135% +$180K 0.01% 1043
2020
Q2
$92K Buy
+28,200
New +$268K ﹤0.01% 912

Other funds holding CEMI

Susquehanna Fundamental Investments's CEMI Position: Q4 2022 in Review

Susquehanna Fundamental Investments sold out of Chembio diagnostics, Inc. (CEMI) in Q4 2022, closing a stake of 29,000 shares — an estimated $10K sold.

Susquehanna Fundamental Investments first reported a position in CEMI in Q2 2020 and held it in 8 quarters. The position peaked at $449K in Q3 2021. 38 funds tracked by Wall St. Rank hold CEMI as of Q4 2022.

  • Susquehanna Fundamental Investments reported no remaining Chembio diagnostics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 29,000 Chembio diagnostics, Inc. shares in Q4 2022, an estimated $10K.
  • Susquehanna Fundamental Investments first reported a position in Chembio diagnostics, Inc. in Q2 2020 and held it in 8 quarters.
  • Susquehanna Fundamental Investments's Chembio diagnostics, Inc. position peaked at $449K in Q3 2021.
  • 38 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2022, filed 14 Feb 2023.